Los Angeles Capital Management LLC Editas Medicine, Inc. Transaction History

Los Angeles Capital Management LLC

  • $26.1 Billion
  • Q2 2025

A detailed history of Los Angeles Capital Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 135,965 shares of EDIT stock, worth $300,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135,965
Previous 162,130 16.14%
Holding current value
$300,482
Previous $188,000 59.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025
SELL
$0.98 - $2.35 $25,641 - $61,487
-26,165 Reduced 16.14%
135,965 $299,000
Q1 2025

May 05, 2025
BUY
$1.14 - $3.2 $72,151 - $202,531
63,291 Added 64.03%
162,130 $188,000
Q4 2024

Feb 04, 2025
SELL
$1.2 - $3.76 $22,560 - $70,688
-18,800 Reduced 15.98%
98,839 $125,000
Q3 2024

Nov 04, 2024
SELL
$3.39 - $5.96 $45,120 - $79,327
-13,310 Reduced 10.16%
117,639 $401,000
Q2 2024

Aug 05, 2024
SELL
$4.67 - $7.28 $79,081 - $123,279
-16,934 Reduced 11.45%
130,949 $611,000
Q1 2024

Apr 05, 2024
BUY
$7.03 - $11.07 $1.04 Million - $1.64 Million
147,883 New
147,883 $1.1 Million
Q3 2022

Nov 02, 2022
BUY
$12.16 - $19.42 $4,705 - $7,515
387 Added 1.07%
36,453 $446,000
Q2 2022

Aug 05, 2022
BUY
$9.99 - $21.35 $41,728 - $89,178
4,177 Added 13.1%
36,066 $427,000
Q1 2022

May 06, 2022
BUY
$14.08 - $27.63 $221,689 - $435,034
15,745 Added 97.53%
31,889 $607,000
Q4 2021

Feb 03, 2022
SELL
$26.55 - $40.57 $4,433 - $6,775
-167 Reduced 1.02%
16,144 $429,000
Q2 2021

Aug 05, 2021
SELL
$31.29 - $56.64 $123,282 - $223,161
-3,940 Reduced 19.46%
16,311 $924,000
Q1 2021

May 05, 2021
SELL
$39.71 - $90.58 $738,645 - $1.68 Million
-18,601 Reduced 47.88%
20,251 $850,000
Q4 2020

Feb 04, 2021
SELL
$27.07 - $84.35 $183,805 - $572,736
-6,790 Reduced 14.88%
38,852 $2.72 Million
Q3 2020

Nov 02, 2020
SELL
$28.06 - $37.16 $389,753 - $516,152
-13,890 Reduced 23.33%
45,642 $1.28 Million
Q2 2020

Aug 05, 2020
SELL
$18.5 - $34.34 $56,795 - $105,423
-3,070 Reduced 4.9%
59,532 $1.76 Million
Q1 2020

May 04, 2020
BUY
$14.88 - $32.78 $61,082 - $134,561
4,105 Added 7.02%
62,602 $1.24 Million
Q4 2019

Feb 07, 2020
BUY
$19.49 - $32.63 $1.14 Million - $1.91 Million
58,497 New
58,497 $1.73 Million
Q3 2019

Nov 07, 2019
SELL
$22.49 - $26.81 $285,735 - $340,621
-12,705 Closed
0 $0
Q2 2019

Jul 29, 2019
SELL
$20.48 - $27.76 $106,905 - $144,907
-5,220 Reduced 29.12%
12,705 $314,000
Q1 2019

Apr 25, 2019
BUY
$19.43 - $26.41 $348,282 - $473,399
17,925 New
17,925 $438,000

Others Institutions Holding EDIT

# of Institutions
223
Shares Held
47.8M
Call Options Held
436K
Put Options Held
324K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $152M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email